Carlo J. Iasella - Concepedia

Author

Carlo J. Iasella

University of Pittsburgh ORCID

Also Known As

C. Iasella, C.J. Iasella, CARLO J IASELLA, Carlo Iasella, Carlo J Iasella, Carlo J. Iasella

Publications

776

Citations

H-Index

Concepts

All Affiliations

University of Pittsburgh University of Pittsburgh Medical Center UPMC Presbyterian Johns Hopkins Medicine Johns Hopkins University

About

Carlo J. Iasella is an author at University of Pittsburgh specializing in medicine, lung transplantation, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	137
2	Health Sciences	1	1	20
3	Allergy	1	1	34
4	Emergency Medicine	1	1	20
5	Hepatology	1	1	20

Carlo J. Iasella

Publications

599

Citations

H-Index

Page 1

	Year	Citations
Impaired Cytomegalovirus Immunity in Idiopathic Pulmonary Fibrosis Lung Transplant Recipients with Short Telomeres Iulia Popescu, H. Mannem, Spencer Winters, American Journal of Respiratory and Critical Care Medicine	2018	103
Effectiveness and Safety of Direct Oral Anticoagulants versus Warfarin in Obese Patients with Acute Venous Thromboembolism James C. Coons, Lauren Albert, Andrea Bejjani, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	2020	69
Maintenance Belatacept-Based Immunosuppression in Lung Transplantation Recipients Who Failed Calcineurin Inhibitors Carlo J. Iasella, Ryan Winstead, Cody A. Moore, Transplantation	2017	66
Increasing tacrolimus time-in-therapeutic range is associated with superior one-year outcomes in lung transplant recipients Christopher R. Ensor, Carlo J. Iasella, Kate M. Harrigan, American Journal of Transplantation	2018	51
Lung transplantation for idiopathic pulmonary fibrosis enriches for individuals with telomere-mediated disease Jonathan K. Alder, Rachel M. Sutton, Carlo J. Iasella, The Journal of Heart and Lung Transplantation	2021	47
Triple Antithrombotic Therapy With Aspirin, P2Y12 Inhibitor, and Warfarin After Percutaneous Coronary Intervention Nathan J. Verlinden, James C. Coons, Carlo J. Iasella, Journal of Cardiovascular Pharmacology and Therapeutics	2017	37
Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction Carlo J. Iasella, Christopher R. Ensor, Marilyn Marrari, The Journal of Heart and Lung Transplantation Transplant RejectionTransplantationHuman Leukocyte AntigenMedicineIncrease Risk	2020	34
Type-1 immunity and endogenous immune regulators predominate in the airway transcriptome during chronic lung allograft dysfunction Carlo J. Iasella, Aki Hoji, Iulia Popescu, American Journal of Transplantation AsthmaType-1 ImmunityInflammatory Lung DiseaseLung InflammationImmune Regulation	2020	34
CD4<sup>+</sup> T-Cell Dysfunction in Severe COVID-19 Disease Is Tumor Necrosis Factor-α/Tumor Necrosis Factor Receptor 1-Dependent. Iulia Popescu, Mark E. Snyder, Carlo J. Iasella, PubMed	2022	26
Lung transplant recipients with telomere-mediated pulmonary fibrosis have increased risk for hematologic complications S. Hannan, Carlo J. Iasella, Rachel M. Sutton, American Journal of Transplantation TransplantationMedicineHematologyImmunologyPathology	2023	21

Page 1